Carcinoma de colon
TP53, 17P and 18Q alterations as
prognostic markers in MSS colorectal adenocarcinomas
MSI status modulates
the value of some molecular markers in colorectal tumors
Molecular evaluation of TP53 status in human
colorectal and urinary bladder cancer: phenotype versus genotype analysis
Lack of p53 nuclear immunostaining is not
indicative of absence of TP53 gene mutations in colorectal adenocarcinomas
Microsatellite analysis of
chromosome 18 in colorectal cancer
BRAF mutations in
colorectal cancer are linked to loss of hMLH1 expression and proximal
location, while independent of K-RAS activation
A novel
logistic model based on clinicopathological features predicts microsatellite
instability in colorectal carcinomas
A novel multiplexing, PCR-based
assay of the analysis of chromosome
18q status in colorectal cancer
La
inestabilidad de microsatélites en el cáncer colorrectal puede predecirse en
base al fenotipo tumoral (Póster presentado en "XXII Congreso de la Sociedad
Española de Anatomía Patológica 2005")
Estudio mutacional de BRAF y KRAS en cáncer colorrectal: carcinoma
esporádico versus síndrome familiar no asociado a poliposis
(Póster presentado en "X Congreso Nacional de la Sociedad
Española de Oncología Médica 2005")
A population study on the
UGT1A1*28 variant associated to Irinotecan tolerance
Colo-
rectal micropapillary carcinoma: a clinicopathological and molecular study
of 27 cases
Multicentric validation
of a model based on phenotypic features to predict microsatellite instability in
colorectal adenocarcinoma
Fórmula de predicción de
inestabilidad de microsatélites en el cáncer colorectal en base a parámetros
morfológicos. Estudio multicéntrico prospectivo de validación y optimización del
modelo.
KRAS mutations correlates with P53
status in colorectal carcinomas.
Carcinoma de mama
Marcadores de pronóstico en el carcinoma de
mama
HER-2/neu status
in breast carcinoma: overexpression versus amplification
Molecular protocol
for HER2/neu analysis in breast carcinoma
Topoisomerase II-Alpha
Gene Copy Number Alterations in ERBB2-Positive Primary Breast Carcinomas: A
Fluorescence In Situ Hybridization Study
La pérdida de
topoisomerasa II alfa está en relación con polisomía del
cromosoma 17 en el carcinoma de mama con amplificación de ERBB2 (HER2).
Carcinoma de vejiga
urinaria
Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations
are associated with tumor progression
Hibridació in situ
Fluorescent - FISH - en la detecció del carcinoma urotelial
Comparison of fluorescense
in situ hybridization –FISH– and conventional cytology for early
detection of urothelial carcinoma
Carcinoma de pulmón
Diagnostic
sub-classification of non-small cell lung cancer: Importance in clinical
therapeutics and prognostication
Carcinoma de pulmón de células no pequeñas: caracterización inmunohistoquímica y
estudio molecular del gen del receptor de EGF (Póster presentado en "XXII
Congreso de la Sociedad Española de Anatomía Patológica 2005")
Epidermal growth
factor receptor in non small cell lung cancer: Gene copy number and mutational
study
Genetic alterations of the epidermal growth
factor receptor pathway in a series of non-small cell lung cancer characterized
by morphology and immunophenotype
Otras publicaciones
Human papillomavirus and
anogenital pathology
Importancia del polimorfismo 5569G/A del intrón 4 del gen HFE en el diagnóstico
de la hemocromatosis hereditaria
Ki-67 and P16INK4A
immunoexpression strongly correlates with increasing grade of CIN and HPV
infection
